By Rathindra Kuruwita Around 70 percent of annual cancer-related deaths occur in lower-middle-income countries, with breast cancer being one of the leading causes, according to Dr. Buddhini Denuwara, ...

Proposition 14 passed by 51.09% to 48.91%, a far cry from 2004. Twenty years and many billions of dollars later, CIRM-funded ...

Any plan to keep our companies at home? 3 Hori7on to release new single on Nov. 3 ...

Plus: Here’s how Epic founder and CEO Judy Faulkner will keep her medical records company private, independent and ...

Prescribed by prime time ...

Prime Medicine, Inc. has recently entered into a strategic research collaboration and license agreement with Bristol Myers Squibb (BMS) to develop and commercialize multiple prime edited ex vivo ...

Prime Medicine, Inc. (PRME – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...

Week 4 is in the books and oh my there's a lot of panic on these fantasy streets. Scott Pianowski joins Matt Harmon for ...

BMO Capital analyst Kostas Biliouris has reiterated their bullish stance on PRME stock, giving a Buy rating yesterday. Kostas Biliouris has ...

Regenerative medicine is the branch of medicine that develops methods to regrow, repair or replace damaged or diseased cells, organs or tissues. Regenerative medicine includes the generation and ...

Shares of Prime Medicine, Inc. PRME were up 11.85% after the company announced a strategic research collaboration and license agreement with biotech giant Bristol Myers Squibb BMY. The collaboration ...